326 related articles for article (PubMed ID: 35583973)
1. Human
Wei AD; Wakenight P; Zwingman TA; Bard AM; Sahai N; Willemsen MH; Schelhaas HJ; Stegmann APA; Verhoeven JS; de Man SA; Wessels MW; Kleefstra T; Shinde DN; Helbig KL; Basinger A; Wagner VF; Rodriguez-Buritica D; Bryant E; Millichap JJ; Millen KJ; Dobyns WB; Ramirez JM; Kalume FK
J Neurophysiol; 2022 Jul; 128(1):40-61. PubMed ID: 35583973
[TBL] [Abstract][Full Text] [Related]
2. Loss-of-Function and Gain-of-Function Mutations in KCNQ5 Cause Intellectual Disability or Epileptic Encephalopathy.
Lehman A; Thouta S; Mancini GMS; Naidu S; van Slegtenhorst M; McWalter K; Person R; Mwenifumbo J; Salvarinova R; ; ; Guella I; McKenzie MB; Datta A; Connolly MB; Kalkhoran SM; Poburko D; Friedman JM; Farrer MJ; Demos M; Desai S; Claydon T
Am J Hum Genet; 2017 Jul; 101(1):65-74. PubMed ID: 28669405
[TBL] [Abstract][Full Text] [Related]
3. Loss-of-function variants in the KCNQ5 gene are implicated in genetic generalized epilepsies.
Krüger J; Schubert J; Kegele J; Labalme A; Mao M; Heighway J; Seebohm G; Yan P; Koko M; Aslan-Kara K; Caglayan H; Steinhoff BJ; Weber YG; Keo-Kosal P; Berkovic SF; Hildebrand MS; Petrou S; Krause R; May P; Lesca G; Maljevic S; Lerche H
EBioMedicine; 2022 Oct; 84():104244. PubMed ID: 36088682
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment.
Bayat A; Iavarone S; Miceli F; Jakobsen AV; Johannesen KM; Nikanorova M; Ploski R; Szymanska K; Flamini R; Cooper EC; Weckhuysen S; Taglialatela M; Møller RS
Neurotherapeutics; 2024 Jan; 21(1):e00296. PubMed ID: 38241158
[TBL] [Abstract][Full Text] [Related]
5. CACNA1I gain-of-function mutations differentially affect channel gating and cause neurodevelopmental disorders.
El Ghaleb Y; Schneeberger PE; Fernández-Quintero ML; Geisler SM; Pelizzari S; Polstra AM; van Hagen JM; Denecke J; Campiglio M; Liedl KR; Stevens CA; Person RE; Rentas S; Marsh ED; Conlin LK; Tuluc P; Kutsche K; Flucher BE
Brain; 2021 Aug; 144(7):2092-2106. PubMed ID: 33704440
[TBL] [Abstract][Full Text] [Related]
6. De novo variants in KCNA3 cause developmental and epileptic encephalopathy.
Soldovieri MV; Ambrosino P; Mosca I; Servettini I; Pietrunti F; Belperio G; ; Syrbe S; Taglialatela M; Lemke JR
Ann Neurol; 2024 Feb; 95(2):365-376. PubMed ID: 37964487
[TBL] [Abstract][Full Text] [Related]
7. Gain of function due to increased opening probability by two
Nappi M; Barrese V; Carotenuto L; Lesca G; Labalme A; Ville D; Smol T; Rama M; Dieux-Coeslier A; Rivier-Ringenbach C; Soldovieri MV; Ambrosino P; Mosca I; Pusch M; Miceli F; Taglialatela M
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2116887119. PubMed ID: 35377796
[TBL] [Abstract][Full Text] [Related]
8. The genotype-phenotype correlations of the
Kessi M; Chen B; Pang N; Yang L; Peng J; He F; Yin F
Front Mol Neurosci; 2023; 16():1222321. PubMed ID: 37555011
[TBL] [Abstract][Full Text] [Related]
9. A novel KCNQ2 missense variant in non-syndromic intellectual disability causes mild gain-of-function of Kv7.2 channel.
Xiong J; Chen S; Chen B; Zhang W; Chen C; Deng X; He F; Zhang C; Yang L; Wang Y; Peng J; Yin F
Clin Chim Acta; 2022 May; 530():74-80. PubMed ID: 35247435
[TBL] [Abstract][Full Text] [Related]
10. Monoallelic and bi-allelic variants in NCDN cause neurodevelopmental delay, intellectual disability, and epilepsy.
Fatima A; Hoeber J; Schuster J; Koshimizu E; Maya-Gonzalez C; Keren B; Mignot C; Akram T; Ali Z; Miyatake S; Tanigawa J; Koike T; Kato M; Murakami Y; Abdullah U; Ali MA; Fadoul R; Laan L; Castillejo-López C; Liik M; Jin Z; Birnir B; Matsumoto N; Baig SM; Klar J; Dahl N
Am J Hum Genet; 2021 Apr; 108(4):739-748. PubMed ID: 33711248
[TBL] [Abstract][Full Text] [Related]
11. Synaptic Dysfunction by Mutations in
Elmasri M; Lotti JS; Aziz W; Steele OG; Karachaliou E; Sakimura K; Hansen KB; Penn AC
Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741674
[No Abstract] [Full Text] [Related]
12. De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes.
Liang L; Li X; Moutton S; Schrier Vergano SA; Cogné B; Saint-Martin A; Hurst ACE; Hu Y; Bodamer O; Thevenon J; Hung CY; Isidor B; Gerard B; Rega A; Nambot S; Lehalle D; Duffourd Y; Thauvin-Robinet C; Faivre L; Bézieau S; Dure LS; Helbling DC; Bick D; Xu C; Chen Q; Mancini GMS; Vitobello A; Wang QK
Hum Mol Genet; 2019 Sep; 28(17):2937-2951. PubMed ID: 31152168
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing Loss-of-Function and Gain-of-Function
Hack JB; Horning K; Juroske Short DM; Schreiber JM; Watkins JC; Hammer MF
Neurol Genet; 2023 Jun; 9(3):e200060. PubMed ID: 37152443
[TBL] [Abstract][Full Text] [Related]
14. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy.
Blanchard MG; Willemsen MH; Walker JB; Dib-Hajj SD; Waxman SG; Jongmans MC; Kleefstra T; van de Warrenburg BP; Praamstra P; Nicolai J; Yntema HG; Bindels RJ; Meisler MH; Kamsteeg EJ
J Med Genet; 2015 May; 52(5):330-7. PubMed ID: 25725044
[TBL] [Abstract][Full Text] [Related]
15. HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyond.
Marini C; Porro A; Rastetter A; Dalle C; Rivolta I; Bauer D; Oegema R; Nava C; Parrini E; Mei D; Mercer C; Dhamija R; Chambers C; Coubes C; Thévenon J; Kuentz P; Julia S; Pasquier L; Dubourg C; Carré W; Rosati A; Melani F; Pisano T; Giardino M; Innes AM; Alembik Y; Scheidecker S; Santos M; Figueiroa S; Garrido C; Fusco C; Frattini D; Spagnoli C; Binda A; Granata T; Ragona F; Freri E; Franceschetti S; Canafoglia L; Castellotti B; Gellera C; Milanesi R; Mancardi MM; Clark DR; Kok F; Helbig KL; Ichikawa S; Sadler L; Neupauerová J; Laššuthova P; Šterbová K; Laridon A; Brilstra E; Koeleman B; Lemke JR; Zara F; Striano P; Soblet J; Smits G; Deconinck N; Barbuti A; DiFrancesco D; LeGuern E; Guerrini R; Santoro B; Hamacher K; Thiel G; Moroni A; DiFrancesco JC; Depienne C
Brain; 2018 Nov; 141(11):3160-3178. PubMed ID: 30351409
[TBL] [Abstract][Full Text] [Related]
16. Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders.
Stolz JR; Foote KM; Veenstra-Knol HE; Pfundt R; Ten Broeke SW; de Leeuw N; Roht L; Pajusalu S; Part R; Rebane I; Õunap K; Stark Z; Kirk EP; Lawson JA; Lunke S; Christodoulou J; Louie RJ; Rogers RC; Davis JM; Innes AM; Wei XC; Keren B; Mignot C; Lebel RR; Sperber SM; Sakonju A; Dosa N; Barge-Schaapveld DQCM; Peeters-Scholte CMPCD; Ruivenkamp CAL; van Bon BW; Kennedy J; Low KJ; Ellard S; Pang L; Junewick JJ; Mark PR; Carvill GL; Swanson GT
Am J Hum Genet; 2021 Sep; 108(9):1692-1709. PubMed ID: 34375587
[TBL] [Abstract][Full Text] [Related]
17. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
18. Intragenic duplication of KCNQ5 gene results in aberrant splicing leading to a premature termination codon in a patient with intellectual disability.
Rosti G; Tassano E; Bossi S; Divizia MT; Ronchetto P; Servetti M; Lerone M; Pisciotta L; Mancardi MM; Veneselli E; Puliti A
Eur J Med Genet; 2019 Sep; 62(9):103555. PubMed ID: 30359776
[TBL] [Abstract][Full Text] [Related]
19. De novo KCNA6 variants with attenuated K
Salpietro V; Galassi Deforie V; Efthymiou S; O'Connor E; Marcé-Grau A; Maroofian R; Striano P; Zara F; Morrow MM; ; Reich A; Blevins A; Sala-Coromina J; Accogli A; Fortuna S; Alesandrini M; Au PYB; Singhal NS; Cogne B; Isidor B; Hanna MG; Macaya A; Kullmann DM; Houlden H; Männikkö R
Epilepsia; 2023 Feb; 64(2):443-455. PubMed ID: 36318112
[TBL] [Abstract][Full Text] [Related]
20. KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties.
Cioclu MC; Mosca I; Ambrosino P; Puzo D; Bayat A; Wortmann SB; Koch J; Strehlow V; Shirai K; Matsumoto N; Sanders SJ; Michaud V; Legendre M; Riva A; Striano P; Muhle H; Pendziwiat M; Lesca G; Mangano GD; Nardello R; ; Lemke JR; Møller RS; Soldovieri MV; Rubboli G; Taglialatela M
Ann Neurol; 2023 Aug; 94(2):332-349. PubMed ID: 37062836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]